Hypersensitivity to the active substance or to any of the excipients:
Sodium dihydrogen phosphate monohydrate
Disodium hydrogen phosphate heptahydrate
Water for injections
Sepsis or risk of sepsis.
Treatment with Benepali™ should not be initiated in patients with active infections, including chronic or localised infections.
See the full Summary of Product Characteristics for further information.